Telehealth companies pivoted when obesity drugs became blockbusters Telehealth companies like Vida Health existed before obesity drugs became blockbusters, says Jayne Hornung, the chief clinical officer at MMIT, a data company focused on the pharmaceuticals market
If Phase 3 trials confirm these results, retatrutide could significantly shift the treatment paradigm
Nelson VL, Jiang YP, Dickman KG, Ballou LM, Lin RZ (2014) Adipose tissue insulin resistance due to loss of PI3K p110 leads to decreased energy expenditure and obesity
Neuroprotection Recent studies have identified GLP-1 receptors in the brain, specifically in the hippocampus and prefrontal cortex
Implications for treatment and the future of personalized medicine This study underscores the need for including female subjects in pre-clinical studies, along with the potential of developing personalized dosing strategies for GLP-1 therapies
With the increasing uptake of GLP-1 agonists like Ozempic and Wegovy, consumer behavior and preferences will inevitably change
